BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11278163)

  • 1. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles.
    Janciauskiene S
    Biochim Biophys Acta; 2001 Mar; 1535(3):221-35. PubMed ID: 11278163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Lys335 in the metastability and function of inhibitory serpins.
    Im H; Yu MH
    Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the serpin superfamily.
    Law RH; Zhang Q; McGowan S; Buckle AM; Silverman GA; Wong W; Rosado CJ; Langendorf CG; Pike RN; Bird PI; Whisstock JC
    Genome Biol; 2006; 7(5):216. PubMed ID: 16737556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tip of another iceberg: Drosophila serpins.
    Reichhart JM
    Trends Cell Biol; 2005 Dec; 15(12):659-65. PubMed ID: 16260136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The native metastability and misfolding of serine protease inhibitors.
    Cho YL; Chae YK; Jung CH; Kim MJ; Na YR; Kim YH; Kang SJ; Im H
    Protein Pept Lett; 2005 Jul; 12(5):477-81. PubMed ID: 16029161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do dysfunctional serpins tell us about molecular mobility and disease?
    Stein PE; Carrell RW
    Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
    Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
    J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering thermostability in serine protease inhibitors.
    Im H; Ryu MJ; Yu MH
    Protein Eng Des Sel; 2004 Apr; 17(4):325-31. PubMed ID: 15126675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of conformational change in serpin structure and function.
    Gettins P; Patston PA; Schapira M
    Bioessays; 1993 Jul; 15(7):461-7. PubMed ID: 8379949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.
    Gettins PG; Olson ST
    Biochem J; 2016 Aug; 473(15):2273-93. PubMed ID: 27470592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmolytes as modulators of conformational changes in serpins.
    Chow MK; Devlin GL; Bottomley SP
    Biol Chem; 2001 Nov; 382(11):1593-9. PubMed ID: 11767949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution structure of cleaved Serpin 42 Da from Drosophila melanogaster.
    Ellisdon AM; Zhang Q; Henstridge MA; Johnson TK; Warr CG; Law RH; Whisstock JC
    BMC Struct Biol; 2014 Apr; 14():14. PubMed ID: 24758516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serpins in vertebrate immunity.
    Mangan MS; Kaiserman D; Bird PI
    Tissue Antigens; 2008 Jul; 72(1):1-10. PubMed ID: 18498291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpins for diagnosis and therapy in cancer.
    Zheng D; Chen H; Davids J; Bryant M; Lucas A
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
    Shin JS; Yu MH
    J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpins and other covalent protease inhibitors.
    Ye S; Goldsmith EJ
    Curr Opin Struct Biol; 2001 Dec; 11(6):740-5. PubMed ID: 11751056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a serpin-protease complex shows inhibition by deformation.
    Huntington JA; Read RJ; Carrell RW
    Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.